Better Health for All

iRadimed Corporation's core business is the development and manufacture of MRI-compatible products, such as IV infusion pumps and patient vital signs monitoring systems, which are designed to safely deliver medications and monitor patients during MRI procedures.

This indicates that 95-97% of its product portfolio delivers exceptional health benefits, with the entire business devoted to health improvement. The company's products are designed to prevent harm, meaning it has no products with significant negative health impacts by design. However, the company's safety record shows two notable incidents within the past three years: one adverse event in September 2024 where an infusion pump administered an entire dose of propofol instead of the programmed amount, leading to a patient's cardiac arrest and hospitalization; and a recall (z-1310-2023) for the 1057 MRI Syringe Adapter Set due to inlet occlusions, reported by a customer in March 2023. The manufacturer was unaware of this issue prior to the recall response, indicating a reactive safety approach and suggesting that risk disclosures are incomplete. The development of the MRidium® 3870 Infusion Pump System, which received FDA 510(k) clearance in May 2025, represents a significant investment in MRI-compatible medical technology, aligning with 10-11% of R&D budget for health improvement. The company promotes education on MRI safety and device compatibility, indicating substantial health education initiatives with broad reach.

Fair Money & Economic Opportunity

iRadimed Corporation is a medical device company that develops, manufactures, and markets MRI compatible products to hospitals and healthcare facilities.

Its core business does not involve lending, insuring, moving, or storing money for consumers. Therefore, all KPIs related to fair money and economic opportunity, which are designed for financial institutions and consumer financial products, are not applicable. The company does not offer lending or deposit services, consumer credit products, or financial education programs. It does not generate or manage customer finance data, nor is it regulated as a lender. Evidence regarding product interfaces for medical devices or director financial literacy does not pertain to the financial product simplicity or financial literacy initiatives for customers as defined by the rubric.

Fair Pay & Worker Respect

The company has an employee rating of 4.2 out of 5 stars, based on 15 anonymous reviews.

84% of employees would recommend working at the company to a friend, and 100% approve of the CEO. The compensation and benefits rating is 4.0 out of 5, showing a 2% improvement over the last 12 months. Employees also rated Work/Life Balance at 4.3 out of 5 and Culture & Values at 4.2 out of 5.

Fair Trade & Ethical Sourcing

No information related to Fair Trade & Ethical Sourcing, or any of the associated metrics, was found in the provided articles for IRMD.US.

The articles explicitly state that no data could be extracted for fair_trade_cert_share, audit_frequency, forced_child_labour_incidents, traceability_coverage, remediation_speed, ethical_clause_coverage, materials_risk_index, or supplier_diversity_spend.

Planet-Friendly Business

In 2023, iRadimed Corporation's carbon footprint was 2,345 metric tons of CO2e.

The company sourced 22% of its operational energy from renewables in 2023. The company has a waste reduction target of 18% for 2023, but no actual diversion rate is provided. No environmental compliance violations, fines, or regulatory actions were mentioned across any of the provided articles.

Respect for Cultures & Communities

No specific, concrete data points were found in the provided articles regarding iRadimed Corporation's performance on any of the KPIs related to Respect for Cultures & Communities.

The articles primarily focus on financial performance, carbon footprint without specific data, and product marketing, with no information on community engagement, cultural impact, or related policies.